| Literature DB >> 19476616 |
Abstract
BACKGROUND: Human behavior influences infectious disease transmission, and numerous "prevalence-behavior" models have analyzed this interplay. These previous analyses assumed homogeneously mixing populations without spatial or social structure. However, spatial and social heterogeneity are known to significantly impact transmission dynamics and are particularly relevant for certain diseases. Previous work has demonstrated that social contact structure can change the individual incentive to vaccinate, thus enabling eradication of a disease under a voluntary vaccination policy when the corresponding homogeneous mixing model predicts that eradication is impossible due to free rider effects. Here, we extend this work and characterize the range of possible behavior-prevalence dynamics on a network.Entities:
Mesh:
Year: 2009 PMID: 19476616 PMCID: PMC2695470 DOI: 10.1186/1471-2334-9-77
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Baseline parameter values for SEIR-type infection.
| Parameter | Meaning | Value | Reference |
|---|---|---|---|
| Population size | 5000 | assumption | |
| Initial number of individuals inoculated with smallpox | 10 | assumption | |
| Mean node degree | 10 | assumption, Ref. [ | |
| Scaling constant for probability of infection from neighbours' neighbours | 0.2 | assumption | |
| Probability of node-to-node transmission | 0.02 day-1 | Ref. [ | |
| Perceived probability of node-to-node transmission | 0.02 day-1 | Ref. [ | |
| 1/ | Mean duration of latent period | 12 days | Ref. [ |
| Variance of latent period | 4 days2 | Ref. [ | |
| 1/ | Mean duration of infectious period | 19 days | Ref. [ |
| Variance of infectious period | 4 days2 | Ref. [ | |
| Variance of infectious period | 4 days2 | Ref. [ | |
| Variance of vaccine latent period | 4 days2 | Ref. [ | |
| Probability of death due to infection | 0.3 | Ref. [ | |
| Probability of death due to vaccine-related complications | 0.001 | assumption, Ref. [ | |
| ϵ | Vaccine efficacy | 0.95 | Ref. [ |
| Payoff for individuals with continued susceptibility | 40 life-years | Ref. [ | |
| Payoff for individuals with lifelong immunity | 40 life-years | Ref. [ |
Parameter values selected are similar to those used in Ref. [49], and are intended to represent smallpox-type infections with high case fatality rates where transmission is dominated by close contact transmission to social contacts (e.g. household transmission, nosocomial transmission). Ref. [49] investigates the impact of variations in the node degree ν.
Figure 1Individual payoffs in the Basic Model. Ellipses represent transition states while boxes represent formal states. Parameters on arrows denote transition probabilities and expressions in boxes denote payoffs for entering that state.
Figure 2Individual Payoffs in the Extended Model. Ellipses represent transition states while boxes represent formal states. Parameters on arrows denote transition probabilities and expressions in boxes denote payoffs for entering that state.
Figure 3Results from the Basic Model. Dependence of final epidemic size and final number vaccinated on: probability of death due to disease dwhen d= 0.001 (a), probability of death due to vaccine dwhen d= 0.03 (b), percentage of population with previous immunity (c), and probability to vaccinate ρ (d) in the Basic Model. Error bars represent two standard deviations from the mean across 20 simulations per data point. Note that d= 0.3 (Table 1) lies to the right of the range illustrated in Figure 1a; we did not plot the results for d> 0.07 because they are qualitatively unchanged from the case d= 0.07.
Parameter definitions for the Extended Model.
| Parameter | Meaning |
|---|---|
| Payoff to a person who remains susceptible today | |
| Payoff to a person who has acquired immunity, either through vaccine or through infection and who did not experience long-term complications from vaccine or infection | |
| Number of infectious neighbors for an individual on a given day | |
| Number of infectious neighbors' neighbors for an individual on a given day | |
| Probability per day of an individual becoming infected by infectious neighbors | |
| Perceived probability per day of an individual becoming infected by infectious neighbors | |
| Perceived probability per day of an individual becoming infected by infectious neighbors' neighbors | |
| Probability with which an individual will vaccinate today if her/his | |
| 1/ | Duration of the latent period for an infectious individual in the extended model |
| 1/ | Duration of the latent period for a vaccinated individual in the extended model |
The Extended Model results.
| Number of Days | 0 | 10 | 20 | 30 | 40 | 50 |
|---|---|---|---|---|---|---|
| 0 | ||||||
| 10 | ||||||
| 20 | ||||||
| 30 | ||||||
| 40 | ||||||
| 50 | ||||||
Rows represent the duration of the disease latent period 1/ι, while columns represent the duration of the vaccine latent period 1/κ. Final epidemic size is shown using bold numbers and final number vaccinated is italicized. See Table 4 for the corresponding standard deviation values.
Standard deviation values corresponding to the results in Table 3.
| Number of Days | 0 | 10 | 20 | 30 | 40 | 50 |
|---|---|---|---|---|---|---|
| 0 | ± | ± | ± | ± | ± | ± |
| 10 | ± | ± | ± | ± | ± | ± |
| 20 | ± | ± | ± | ± | ± | ± |
| 30 | ± | ± | ± | ± | ± | ± |
| 40 | ± | ± | ± | ± | ± | ± |
| 50 | ± | ± | ± | ± | ± | ± |
Rows represent the duration of the disease latent period 1/ι, while columns represent the duration of the vaccine latent period 1/κ. Standard deviation values for the final epidemic size (bold numbers) and for the final number vaccinated (italicized numbers) are calculated based on the results from 20 simulations per data point.